Ask a Question

User radioshark3

Member for: 2 years (since Jan 26, 2023)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/mk-4827.html
About: Risk of Earlier Further advancement Based on Circulating ENiraparib Mutation, CA-153 and cfDNA Increases Below First-Line Anti-Aromatase Treatment within Metastatic Breast Cancer

Activity by radioshark3

Score: 100 points (ranked #11)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for radioshark3

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...